Agilent Technologies and the National University of Singapore (NUS) have announced an agreement to develop expertise and knowledge in the area of analytical lipidomics.
The goal of the partnership is to develop workflow solutions that enable researchers to more accurately understand disease states.
Under the terms of the agreement, Agilent's provision of sophisticated test and measurement instruments will be housed in the NUS Center for Lipidomics within the university's Life Sciences Institute.
Headed by associate professor Markus Wenk, NUS Department of Biochemistry and Department of Biological Sciences, this centre will host researchers and scientists from clinical and commercial organisations in Singapore and the Asia Pacific region.
The centre grew out of a competitive five-year research programme and promises to be a global magnet for collaborating parties in lipidomics.
The collaboration will help to further advances in the emerging field of lipidomics, which may lead to the creation of new classes of biomedical research tools and therapies.
Agilent will support NUS with specialised instruments for the separation and analysis of lipids from complex mixtures using robotic systems and the latest bioinformatics software tools and electronic lab notebooks.
The company will also allow NUS access to its scientists in Asia and the US.
NUS will serve as a reference site for Agilent and allow the company to better understand the needs of the research community.
Agilent will use what it learns to further develop and enhance its instruments.
Additionally, both Agilent and NUS have agreed to explore opportunities in the field of lipidomics through collaborative research projects, short-term consultancies, customised training programmes and workshops, and participation at industry seminars and conferences to advance the level of knowledge in the field of lipidomics.
